Cyclerion Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyclerion Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Cyclerion Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$1.22M -100% Dec 31, 2023 10-K 2024-03-05
Q3 2023 $0 -$1.26M -100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.13M -$185K -14.1% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $1.17M -$185K -13.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.22M -$184K -13.1% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $1.26M -$185K -12.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.31M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.36M -$41M -96.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.4M -$42M -96.8% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $1.45M -$42.9M -96.7% Sep 30, 2021 10-Q 2021-11-09
Q1 2021 $42.4M -$9.86M -18.9% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $43.4M -$24.7M -36.3% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $44.4M -$24.8M -35.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $51.3M -$19M -27.1% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 $52.3M -$19M -26.7% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $68.1M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $69.2M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $70.3M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $71.3M Apr 1, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.